Last Posted: Feb 28, 2019
- Recent trends in treatment of thalassemia.
El-Beshlawy Amal et al. Blood cells, molecules & diseases 2019 Feb - Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.
Fasano R M et al. Transfusion medicine (Oxford, England) 2019 Feb - Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
Mirzakhani Mohsen et al. Journal of pediatric hematology/oncology 2019 Jan - Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.
Ghiaccio Valentina et al. Molecular diagnosis & therapy 2019 Jan - Thalassemia Management: Balancing Blood and Iron
Public Health Webinar Series on Blood Disorders. Feb 28, 2019 2:00 PM - 3:00 PM EST - Clinical Classification, Screening and Diagnosis for Thalassemia.
Viprakasit Vip et al. Hematology/oncology clinics of North America 2018 32(2) 193-211 - Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote Karina et al. Clinical biochemistry 2015 Jul 48(10-11) 698-702 - Invasive molecular prenatal diagnosis of alpha and beta thalassemia among Hakka pregnant women.
Wu Heming et al. Medicine 2018 Dec 97(52) e13557 - Rapid Detection of Fetal Mendelian Disorders: Thalassemia and Sickle Cell Syndromes.
Traeger-Synodinos Joanne et al. Methods in molecular biology (Clifton, N.J.) 2019 1885207-219 - Inherited hemolytic anemia: a possessive beginner's guide.
Mohandas Narla et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 377-381
.png)
No hay comentarios:
Publicar un comentario